At the Virtual 2020 ESMO Congress, Ana Carneiro talks about disparities in access to oncology trials from the last decade. The late-breaking abstract ‘Disparities in access to oncology clinical trials in Europe in the period 2009-2019‘ (LBA66) was presented at the Virtual 2020 ESMO Congress, 19–21 September 2020.
- Prior to this study, what was already known about disparities in cancer care and clinical trials across Europe? (0:14)
- Could you tell us a little about the aims and design of this study on access to oncology trials? (0:46)
- What were the findings of this study? (1:20)
- What are the limitations impacting access in clinical trials across European countries? (1:58)
- What can be done to address these inequalities? (2:48)
Speaker Disclosure: Ana Carneiro has nothing to disclose in relation to this interview.
Support: Interview and filming supported by Touch Medical Media Ltd.
Filmed in coverage of the Virtual 2020 ESMO Congress.
Share this Video
Related Videos In Policy
Professor Isabel Rubio: Optimizing Surgical Oncology in Cancer Care in Europe
Integrating surgical oncology into cancer care across Europe can be challenging, but it plays a critical role in cancer care. It was a pleasure to talk to Professor Isabel Rubio, President-Elect of the European Societ of Surgical Oncology (ESSO), to discuss current projects and initiatives of the society for the coming year and the recent […]
Bart Westerman, AACR 2022: An AI Model to Predict Adverse Drug Reactions
We were delighted to catch up with Dr. Bart Westerman (VU Medical Center, Amsterdam UMC, Amsterdam, The Netherlands) to discuss his presentation entitled ‘An AI Model Can Help Predict Adverse Events From New Drug Combinations’, which was presented at AACR 2022, 8-13 April 2022. Questions Why is it important to better predict the benefit-risk profile […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!